Rocket Lab stock closed out May near $130, capping a roughly 60% one-month surge that pushed the space company close to its record high of $139.76 set on May 22. The move has turned RKLB into one of the market’s most closely watched momentum names.
The rally accelerated after first-quarter 2026 results on May 7, when Rocket Lab delivered stronger-than-expected revenue, expanding margins and a record backlog. Investors have since focused on one core question: can the company’s fundamentals, and especially its Neutron rocket program, justify an $87 billion market value?
That question matters because Rocket Lab stock is now trading well above many prior analyst targets, while the company remains unprofitable and heavily dependent on future execution. For investors, the story is no longer just about growth; it is about whether that growth can arrive on time.
Key Facts
- Rocket Lab shares traded near $130 at the end of May, after rising about 60% during the month and touching an all-time high of $139.76 on May 22.
- First-quarter 2026 revenue reached $200.3 million, up 63.5% year over year, while GAAP gross margin improved to 38.2% from 34.4% a year earlier.
- Order backlog climbed to a record $2.2 billion after the company signed 31 launch contracts in the first quarter, exceeding its full-year 2025 total.
- Rocket Lab’s valuation expanded to roughly 46 times forward sales, versus an industry average near 11.64 times, even as EBITDA remained negative at about $175.58 million.
- The company announced a $3 billion common stock offering in May, and the shares fell 8.7% after investors reacted to the dilution impact.
Rocket Lab Stock
The surge in Rocket Lab stock reflects more than speculative enthusiasm. The company posted a quarter that strengthened the growth case: revenue beat expectations, margins moved higher, and backlog reached a new record. That combination signaled a business gaining scale in launch services and space systems, while also giving investors more visibility into future revenue.
Just as important, Rocket Lab continued to announce meaningful contracts. These included its largest agreement to date with a confidential customer covering Electron and Neutron missions through 2029, a $190 million order for 20 hypersonic test flights using HASTE, and a separate $90 million Space Force award. Together, those wins reinforced the view that Rocket Lab is becoming a more important supplier in defense and government space markets, where budgets are large and contract duration can support multi-year growth.
Still, the stock’s valuation now embeds very high expectations. Rocket Lab remains unprofitable, and much of the bull case depends on Neutron, its next-generation medium-lift rocket. Electron gives the company a strong foothold in the small-launch market, but Neutron is the vehicle that could open access to much larger commercial and government payload opportunities. If Neutron launches on schedule and performs well, the current premium could look more defensible. If it slips further, investors may reassess the entire growth narrative.
Rocket Lab is executing strongly, but the stock is now priced for near-flawless delivery of a rocket that has not yet flown.
Why Neutron Matters So Much
Neutron is the central catalyst because it changes Rocket Lab’s addressable market. The medium-lift segment is far larger than the niche served by Electron and is critical for satellite constellations, national security payloads and broader commercial launch demand. Management has targeted a first launch in late 2026 or early 2027, but a qualification setback disclosed in January showed that development risk remains real.
That creates a binary setup for the stock. A successful debut would likely validate years of spending and support the argument that Rocket Lab can evolve into a full-spectrum launch and space infrastructure company. A major delay or technical failure, by contrast, would pressure sentiment quickly because so much of the current valuation is tied to future Neutron revenue rather than present-day profitability.
Implications for Investors
For growth-oriented investors, Rocket Lab offers exposure to several attractive themes at once: rising defense and government spending in space, continued satellite deployment, and the emergence of a publicly traded launch company with expanding vertical integration. The acquisition of space robotics company Motiv Space Systems also suggests Rocket Lab is building beyond launches into higher-value systems and services, which could help diversify revenue over time.
The risk is that Rocket Lab stock has become a high-beta momentum trade as much as a fundamentals story. With a beta of 2.46 and volatility near 6%, the shares can move sharply in both directions. The market has already shown sensitivity to dilution, and the $3 billion equity offering underscored a basic reality of the space industry: ambitious development programs consume large amounts of capital before they generate returns. Additional financing needs cannot be ruled out if spending remains elevated.
Valuation is the other key watch-point. Trading near 46 times forward sales on negative EBITDA leaves little room for disappointment. Investors considering new positions may want to monitor several upcoming markers: the next earnings report, updates on Neutron testing and scheduling, the pace of backlog conversion into revenue, and whether government contract momentum remains strong. Existing shareholders, meanwhile, may view position sizing and risk management as especially important after such a steep run.
Rocket Lab has established itself as one of the most credible public space growth stories, but the stock’s next chapter will likely be decided by execution rather than excitement. Through the second half of 2026, every milestone tied to Neutron, margins and capital needs could have an outsized effect on RKLB shares.
VIP Trading Signals
